Pfizer (PFE)

EBITDA Growth

-69.27%

Quarterly · Period ending:

PFE logo

PFE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-69.27%
PFE Quarterly EBITDA YoY % (14.84% → -69.27%)
High-resolution chart · PNG

PFE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer EBITDA Growth — Quarterly
Period endingEBITDA Growth
-69.2655%
7.8125%
-85.3004%
-22.1288%
121.3306%
-14.9966%
390.565%
761.1668%
-44.7254%
-26.3497%
-125.0566%
-110.4526%
-66.3079%
-23.5227%
30.3802%
10.3691%
50.6533%
45.937%
178.5604%
348.115%
86.6318%
64.5293%
568.3849%
-83.2769%
-24.1829%
-29.3948%
-72.6761%
107.9823%
-5.5651%
3.7475%
-62.7101%
11.5356%
12.5241%
3.2325%
8.883%
66.2109%
39.4228%
9.9017%
86.6904%
-22.51%
-18.5134%
13.782%
-59.7075%
-19.1971%
-13.0329%
0.5839%
-30.26%
-3.2757%
-21.3789%
-21.2266%
12.6634%
12.2032%
17.8199%
16.3298%
-12.2752%
-21.6216%
1.5487%
-11.162%
13.5068%
51.8182%
-6.0355%
-0.734%
176.8323%
-23.3377%
42.3463%
6.6542%
-69.2865%
5.7991%
3.7322%
1.4753%
41.9827%
127.7803%
21.9923%
-12.1323%
-4.4513%
-57.6265%
-25.2475%
6.2323%
-23.817%
5.6493%
4.3029%
2.3306%
-15.5511%
-13.4997%
28.5754%
-0.2523%
32.1743%
54.3826%
29.015%
47.4621%
28.1083%
11.1614%
3.1664%
13.241%
15.9529%
7.3163%
-4.8353%
9.2373%
19.5856%
24.9595%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.